NASDAQ:VANI Vivani Medical (VANI) Stock Price, News & Analysis $1.14 +0.01 (+0.88%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$1.14 0.00 (0.00%) As of 08:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Vivani Medical Stock (NASDAQ:VANI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vivani Medical alerts:Sign Up Key Stats Today's Range$1.13▼$1.1650-Day Range$0.96▼$1.1552-Week Range$0.91▼$2.09Volume54,775 shsAverage Volume161,519 shsMarket Capitalization$67.54 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company OverviewVivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.Read More… Vivani Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreVANI MarketRank™: Vivani Medical scored higher than 65% of companies evaluated by MarketBeat, and ranked 369th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingVivani Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageVivani Medical has only been the subject of 1 research reports in the past 90 days.Read more about Vivani Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Vivani Medical are expected to remain at ($0.41) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vivani Medical is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vivani Medical is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVivani Medical has a P/B Ratio of 2.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Vivani Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.06% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently decreased by 9.10%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVivani Medical does not currently pay a dividend.Dividend GrowthVivani Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.06% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently decreased by 9.10%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment1.03 News SentimentVivani Medical has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Vivani Medical this week, compared to 1 article on an average week.Search Interest1 people have searched for VANI on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $121,636.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders46.40% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 6.78% of the stock of Vivani Medical is held by institutions.Read more about Vivani Medical's insider trading history. Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address VANI Stock News HeadlinesHC Wainwright Weighs in on Vivani Medical Q1 EarningsMay 23, 2025 | americanbankingnews.comHC Wainwright Reiterates Buy Rating for Vivani Medical (NASDAQ:VANI)May 21, 2025 | americanbankingnews.comJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.May 28, 2025 | Premier Gold Co (Ad)Vivani Medical Reports Q1 2025 Results and Strategic UpdatesMay 20, 2025 | tipranks.comVivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deVivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comVivani Medical CEO to Present on Innovative Drug Delivery Solutions at AAPS Virtual WorkshopMay 9, 2025 | nasdaq.comVivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual WorkshopMay 7, 2025 | globenewswire.comSee More Headlines VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed this year? Vivani Medical's stock was trading at $1.16 on January 1st, 2025. Since then, VANI stock has decreased by 1.7% and is now trading at $1.14. View the best growth stocks for 2025 here. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) announced its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01. Who are Vivani Medical's major shareholders? Vivani Medical's top institutional shareholders include Connective Capital Management LLC (0.27%) and Wealthedge Investment Advisors LLC (0.21%). Insiders that own company stock include Gregg Williams, Joachim Eberhard Bolck, Aaron Mendelsohn, Donald Dwyer and Brigid Makes. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vivani Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Second Sight Medical Products (EYES), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB). Company Calendar Last Earnings5/13/2025Today5/27/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:VANI CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees20Year FoundedN/APrice Target and Rating Average Stock Price Target$4.00 High Stock Price Target$4.00 Low Stock Price Target$4.00 Potential Upside/Downside+250.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$25.65 million Net MarginsN/A Pretax MarginN/A Return on Equity-102.42% Return on Assets-49.21% Debt Debt-to-Equity RatioN/A Current Ratio3.41 Quick Ratio3.41 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.41 per share Price / Book2.78Miscellaneous Outstanding Shares59,244,000Free Float32,994,000Market Cap$67.54 million OptionableOptionable Beta2.81 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:VANI) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.